Comprehensive assessment of the efficiency of pathogenetic psoriasis therapy
Psoriatic patients were found to have markedly altered level of certain protein fractions and enhanced content of C-reactive protein, α<sub>1</sub>-protease inhibitor (α<sub>1</sub>-antitrypsin), α<sub>1</sub>-acid glycoprotein (orosomucoid), and nitrogen oxide. Combined therapy including aponil helped to resolve clinical manifestations of psoriasis and resulted in a substantial decrease of globulins, C-reactive protein, α<sub>1</sub>-proteinase inhibitor, α<sub>1</sub>-acid glycoprotein, and nitrogen oxide.